These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 8444658
21. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice. Taheri A, Dinarvand R, Ahadi F, Khorramizadeh MR, Atyabi F. Int J Pharm; 2012 Jul 15; 431(1-2):183-9. PubMed ID: 22531853 [Abstract] [Full Text] [Related]
22. Enhanced intracellular delivery of methotrexate by a receptor-mediated process. Mukhopadhyay A, Basu SK. Biotechnol Appl Biochem; 1990 Oct 15; 12(5):529-36. PubMed ID: 2288708 [Abstract] [Full Text] [Related]
23. Effect of space length of mannose ligand on uptake of mannosylated liposome in RAW 264.7 cells: In vitro and in vivo studies. Jeong HS, Na KS, Hwang H, Oh PS, Kim DH, Lim ST, Sohn MH, Jeong HJ. J Biomed Mater Res A; 2014 Dec 15; 102(12):4545-53. PubMed ID: 24677479 [Abstract] [Full Text] [Related]
24. Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis. Kole L, Das L, Das PK. J Infect Dis; 1999 Sep 15; 180(3):811-20. PubMed ID: 10438370 [Abstract] [Full Text] [Related]
25. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Chaubey P, Mishra B. Carbohydr Polym; 2014 Jan 30; 101():1101-8. PubMed ID: 24299880 [Abstract] [Full Text] [Related]
26. Methotrexate transport mechanisms: the basis for targeted drug delivery and ß-folate-receptor-specific treatment. Fiehn C. Clin Exp Rheumatol; 2010 Jan 30; 28(5 Suppl 61):S40-5. PubMed ID: 21044432 [Abstract] [Full Text] [Related]
27. Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver. Fiume L, Mattioli A, Busi C, Accorsi C. Gut; 1984 Dec 30; 25(12):1392-8. PubMed ID: 6210232 [Abstract] [Full Text] [Related]
28. Morphological analysis of ligand uptake and processing: the role of multivesicular endosomes and CURL in receptor-ligand processing. Harding C, Levy MA, Stahl P. Eur J Cell Biol; 1985 Mar 30; 36(2):230-8. PubMed ID: 2986980 [Abstract] [Full Text] [Related]
29. Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages. Sato Y, Beutler E. J Clin Invest; 1993 May 30; 91(5):1909-17. PubMed ID: 8486762 [Abstract] [Full Text] [Related]
30. Leishmania donovani: in vitro evidence of hepatocyte damage by Kupffer cells and immigrant macrophages in a murine model. Kausalya S, Malla N, Ganguly NK, Mahajan RC. Exp Parasitol; 1993 Nov 30; 77(3):326-33. PubMed ID: 8224088 [Abstract] [Full Text] [Related]
31. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing. Bures L, Bostík J, Motycka K, Spundová M, Rehák L. Neoplasma; 1988 Nov 30; 35(3):329-42. PubMed ID: 3405341 [Abstract] [Full Text] [Related]
32. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Soyer TG, Mendonça DVC, Tavares GSV, Lage DP, Dias DS, Ribeiro PAF, Perin L, Ludolf F, Coelho VTS, Ferreira ACG, Neves PHAS, Matos GF, Chávez-Fumagalli MA, Coimbra ES, Pereira GR, Coelho EAF, Antinarelli LMR. Exp Parasitol; 2019 Apr 30; 199():30-37. PubMed ID: 30817917 [Abstract] [Full Text] [Related]
33. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Beljaars L, Molema G, Weert B, Bonnema H, Olinga P, Groothuis GM, Meijer DK, Poelstra K. Hepatology; 1999 May 30; 29(5):1486-93. PubMed ID: 10216133 [Abstract] [Full Text] [Related]
34. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody. Endo N, Kato Y, Takeda Y, Saito M, Umemoto N, Kishida K, Hara T. Cancer Res; 1987 Feb 15; 47(4):1076-80. PubMed ID: 3802092 [Abstract] [Full Text] [Related]
35. Hepatic processing of recombinant human renin: mechanisms of uptake and degradation. Marks DL, Kost LJ, Kuntz SM, Romero JC, LaRusso NF. Am J Physiol; 1991 Aug 15; 261(2 Pt 1):G349-58. PubMed ID: 1872403 [Abstract] [Full Text] [Related]
36. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats. Stehle G, Sinn H, Wunder A, Schrenk HH, Schütt S, Maier-Borst W, Heene DL. Anticancer Drugs; 1997 Aug 15; 8(7):677-85. PubMed ID: 9311444 [Abstract] [Full Text] [Related]
37. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis. Bansal R, Prakash J, de Ruijter M, Beljaars L, Poelstra K. Mol Pharm; 2011 Oct 03; 8(5):1899-909. PubMed ID: 21800888 [Abstract] [Full Text] [Related]
38. Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis models. Maeda H, Hirata K, Watanabe H, Ishima Y, Chuang VT, Taguchi K, Inatsu A, Kinoshita M, Tanaka M, Sasaki Y, Otagiri M, Maruyama T. J Pharmacol Exp Ther; 2015 Feb 03; 352(2):244-57. PubMed ID: 25398242 [Abstract] [Full Text] [Related]
39. An experimental model system for leishmaniasis. An ultrastructural study on cultured macrophages exposed to Leishmania parasites and sodium stibogluconate. Abok K, Fredriksson BA, Brunk U. APMIS; 1988 Jul 03; 96(7):589-95. PubMed ID: 2841954 [Abstract] [Full Text] [Related]